Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821112) titled 'Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Tx Treated With Cesium-131 GammaTile(R)' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of California, Irvine
Condition:
Glioma
Glioblastoma
GBM
Glioma, Malignant
Astrocytoma
Oligodendroglioma
Elderly Glioblastoma
Elderly GBM
Intervention:
Device: GammaTile(R)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2026
Target Sample Size: 20 ...